HQL

abrdn Life Sciences Investors
HQL

Overview Fund Trends Analyst Outlook Journalist POV

61 hedge funds and large institutions have $50M invested in abrdn Life Sciences Investors in 2019 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 25 increasing their positions, 13 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

more ownership

Funds ownership: →

6% less capital invested

Capital invested by funds: $53.3M → $50M (-$3.29M)

Holders
61
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$665K
2
+$639K
3
+$529K
4
Lido Advisors
Lido Advisors
California
+$302K
5
Bank of America
Bank of America
North Carolina
+$276K

Top Sellers

1
-$750K
2
-$499K
3
-$412K
4
Morgan Stanley
Morgan Stanley
New York
-$390K
5
NIM
Needham Investment Management
New York
-$264K
Name Holding Trade Value Shares
Change 		Change in
Stake
51
$22K
52
$14K
53
$12K
54
$12K
55
$10K
56
$9K
57
$8K
58
–
59
–
60
–
1 2
3